Veracyte, Inc. (VCYT): Cost of Revenue
Older than the company's other figures. The latest Cost of Revenue is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$36.08M
Year ended 2019-12-31
+12.3%
3-year compound annual growth
+16.8%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2019-12-31 | $36.08M | +9.1% | 2020-02-25, From 2019-01-01 |
| 2018-12-31 | $33.08M | +17.3% | 2020-02-25, From 2018-01-01 |
| 2017-12-31 | $28.20M | +10.7% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $25.46M | +18.4% | 2019-02-25, From 2016-01-01 |
| 2015-12-31 | $21.50M | +29.5% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $16.61M | +31.7% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $12.61M | +66.2% | 2016-03-14, From 2013-01-01 |
| 2012-12-31 | $7.58M | +159.3% | 2015-03-25, From 2012-01-01 |
| 2011-12-31 | $2.92M | n/a | 2014-03-20, From 2011-01-01 |